Literature DB >> 8060043

Hepatocellular carcinoma embolus to the common hepatic duct with no detectable primary hepatic tumor.

M J Buckmaster1, R W Schwartz, G E Carnahan, W E Strodel.   

Abstract

Obstruction of the common bile duct (CBD) by direct extension of tumor is occasionally found in patients with hepatic neoplasms. Tumor embolus to the CBD is very rare, however, when no primary hepatic tumor is found. The patient described herein was a 74-year-old man who presented with a new onset of jaundice, nausea, anorexia, and epigastric pain. There was a history of dark urine and clay-colored stools, but no fever. Endoscopic retrograde cholangiopancreatography (ERCP) showed partial obstruction of the common hepatic duct and dilated intrahepatic bile ducts. A computed tomography (CT) scan of the upper abdomen showed no masses. Results of a mesenteric and selective hepatic arteriogram were normal. On abdominal exploration, no tumor was noted. There were no palpable stones in the gallbladder, but a firm mass was felt in the common hepatic duct. Exploration of the CBD produced light-colored debris organized into a cast of the common hepatic duct. Frozen section analysis was negative for tumor cells, but review of the permanent sections confirmed the presence of hepatocellular carcinoma. When non-calculous material is found to be obstructing the CBD, even in the absence of an obvious primary hepatic tumor, tumor embolus or metastasis from a distant site must be considered and the material sent for pathological evaluation.

Entities:  

Mesh:

Year:  1994        PMID: 8060043

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  10 in total

1.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.

Authors:  Xian-huan Yu; Lei-bo Xu; Chao Liu; Rui Zhang; Jie Wang
Journal:  Dig Dis Sci       Date:  2010-05-01       Impact factor: 3.199

3.  Hepatocellular carcinoma presenting as bile duct tumor: a case report.

Authors:  Luca Seriau; Cosimo Alex Leo; Rossano Girometti; Claudio Avellini; Umberto Baccarani; Alessandro Uzzau
Journal:  J Gastrointest Cancer       Date:  2014-12

4.  Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass.

Authors:  Xue-Ying Long; Yi-Xiong Li; Wei Wu; Lang Li; Jue Cao
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

5.  Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients.

Authors:  Lun-Xiu Qin; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Xin-Da Zhou; Hui-Chuan Sun; Qing-Hai Ye; Lu Wang; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

Review 6.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

7.  Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion.

Authors:  Ke-Wei Meng; Mei Dong; Wei-Guo Zhang; Qing-Xian Huang
Journal:  Gastroenterol Res Pract       Date:  2014-03-02       Impact factor: 2.260

8.  The efficacy of endoscopic palliation of obstructive jaundice in hepatocellular carcinoma.

Authors:  Semi Park; Jeong Youp Park; Moon Jae Chung; Jae Bock Chung; Seung Woo Park; Kwang-Hyub Han; Si Young Song; Seungmin Bang
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

9.  Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with Obstructive Jaundice.

Authors:  Esam Elshimi; Wesam Morad
Journal:  Gastrointest Tumors       Date:  2019-11-01

10.  Acute pancreatitis and obstructive jaundice as initial complaints of hepatocellular carcinoma: case report.

Authors:  Guo-Qing Jiang; Jian-Jun Qian; Jie Yao; Sheng-Jie Jin; Dou-Sheng Bai
Journal:  World J Surg Oncol       Date:  2014-01-14       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.